Owing to high high gas prices, the plants are uncompetitive, despite their high efficiency

Tapping companies' archives makes for better predictions of how proteins bind drugs, but any data inputs need to be transparent and attributed

Serious incidents in two university labs highlight the importance of knowing what to do when things go wrong

It's important to be realistic about what AI can, and can't, achieve, across the chemistry enterprise

Rumoured merger between AstraZeneca and Bristol Myers Squibb has collapsed, and that's probably a good thing

Plan aims to encourage domestic US supplies, but will it work?

US and EU plant closures highlight economic difficulties of scaling technology alongside associated policy and infrastructure

Thermo Fisher needs to be open and honest about data manipulation to reassure researchers

US figures suggest an increase in incidents involving serious injuries and fatalities in recent years

Agrochemicals including paraquat remain legal elsewhere, prompting questions over regulatory responsibility

Deal includes two late-stage molecules to augment GSK's renewed cancer therapy pipeline

Strengthening rules on pharmaceutical and chemical trade could protect critical industries

UK steel production has been declining for decades thanks to high costs and cheap imports

Shortages of bitumen, cooking gas and jet fuel are pushing up prices and disrupting construction

$5 billion criminal sentence paves the way for resolution of civil liabilities through bankruptcy court

US, UK and EU all have goals to eliminate animal testing

Conflict's impact on global energy and chemicals supply chains will take significantly longer to resolve

As patents on Novo Nordisk's diabetes and weight loss blockbusters expire, generic makers have their versions ready

Recovering feedstocks from hard-to-recycle plastic is potentially important in a more circular plastic economy

Deyond hydrocarbons, helium and sulfur - byproducts of petroleum extraction - have also been critically affected by Iran's blockade of Gulf exports

Calling artificial colours 'petroleum-based poisons' plays to popular fears, not necessarily evidence

It has been a dramatic week for mRNA vaccine-maker Moderna and the US Food and Drug Administration (FDA). On 10 February, the FDA told Moderna that it would not accept the company's application for a ...

Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention

The UK has set out its approach to regulating fluorochemicals, and the EU has projected the savings from a proposed ban

Industry argues UK proposals are flawed and will not promote decarbonisation

By dismantling scientific enterprise, the US risks 'taking a hammer to our miracle machine'

Pending policies that demand more recycling cannot offset problems of high costs and competition from cheap virgin polymers

UK government agrees £150 million deal to support the country's last ethylene production plant

The new African Medicines Agency is hugely important but faces significant challenges

Chemical dumping claims reflect US and China's focus on national interests ahead of global markets

Memories of a year spent testing new inhaler valve designs

Mechanical labmates are making huge progress, but there are still big challenges to overcome

Lawsuits fly in bidding war over developer of next generation weight loss drugs

University entrepreneurs need more consistent help to bridge the gap betweeen ideas and businesses

Closing skills gaps in key professional groups requires collaboration between government, industry and educators

Will Nobel prize speed porous materials to commercial success?

Taxing branded drug imports could hit biotech innovators hardest

China's rapid capacity expansion fuels global oversupply, leading plant closures in Europe and elsewhere

Merck & Co, AstraZeneca (AZ) and Eli Lilly pulling UK projects highlights the precarious position of the country's life sciences industry

With UK plants facing closure, what are the options and issues around different renewable fuels?

Bacterial conatmination in medical fentanyl has killed at least 51 people in Argentina, highlighting pressures on generic drugmakers

Pills may offer convenience for manufacturers, but it's not clear they will overtake existing drugs

Global plastic treaty negotiations risk being derailed by minority opposed to production caps

Balancing industrial expertise against unwanted commercial influence is not easy but shouldn't be discounted

Managing exposure risks

Reforms and state support have fuelled domestic and foreign investment in pharmaceutical

Basic chemical plant closures highlight strain on European industry

Gilead and its partners' efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets